EXHIBIT 99.2


            SECTION 906 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER
          RELATING TO A PERIODIC REPORT CONTAINING FINANCIAL STATEMENTS


         I, Timothy M. Mayleben, Chief Financial Officer, of Esperion
Therapeutics, Inc., a Delaware corporation (the "Company"), hereby certify that:

         (1) The Company's periodic report on Form 10-Q for the period ended
March 31, 2003 (the "Form 10-Q") fully complies with the requirements of Section
13(a) of the Securities Exchange Act of 1934, as amended; and

         (2) The information contained in the Form 10-Q fairly presents, in all
material respects, the financial condition and results of operations of the
Company.


                                    *   *   *


  /s/ Timothy M. Mayleben
---------------------------
Timothy M. Mayleben,
Chief Financial Officer

Date:    May 14, 2003